Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus

This publication has 39 references indexed in Scilit:

• Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus
  PLOS ONE, 2010
• An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus
  Virology Journal, 2010
• Immunogenicity and Protective Efficacy of a Live Attenuated H5N1 Vaccine in Nonhuman Primates
  PLOS Pathogens, 2009
• In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery
  Biomaterials, 2009
• Highly Pathogenic Avian Influenza Virus (H5N1) in Domestic Poultry and Relationship with Migratory Birds, South Korea
  Emerging Infectious Diseases, 2008
• Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization
  Journal of Virology, 2008
• The threat of avian influenza A (H5N1). Part IV: development of vaccines
  Medical Microbiology and Immunology, 2007
• Activation of NF-κB by the intracellular expression of NF-κB-inducing kinase acts as a powerful vaccine adjuvant
  Proceedings of the National Academy of Sciences, 2006
• In vitro Enzymatic Degradation of Nanoparticles Prepared from Hydrophobically‐Modified Poly(γ‐glutamic acid)
  Macromolecular Bioscience, 2005
• Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice
  European Journal of Pharmaceutics and Biopharmaceutics, 2004